Camillo blames vacation travel for COVID-19 uptick in Greenwich
FacebookTwitterEmail
1of3
Employees check in patients during the Greenwich Hospital COVID-19 vaccine clinic at the Brunswick Lower School Campus in Greenwich, Conn. Monday, Jan. 25, 2021.Tyler Sizemore / Hearst Connecticut MediaShow MoreShow Less
2of3
Greenwich First Selectman Fred Camillo continues to stress following safety protocols even with warm weather arriving and more vaccine eligibility opening. Greenwich’s COVID cases, like the state’s, are on the rise.Tyler Sizemore / Hearst Connecticut MediaShow MoreShow Less
3of3
GREENWICH Calling it a “big jump,” First Selectman Fred Camillo reported Wednesday that the number of COVID-19 cases in Greenwich is continuing to rise.
Mayor - Milford residents 45 and older now vaccine eligible middletownpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from middletownpress.com Daily Mail and Mail on Sunday newspapers.
Public hearing set for cancer center is next big step for $80M Danbury facility
FacebookTwitterEmail
A rendering of the proposed Danbury Proton treatment center.Contributed image
DANBURY - An $80 million cancer treatment center that would use a novel type of radiation to kill more tumor cells and less healthy tissue will be the subject of a public hearing in two weeks.
The state Office of Health Strategy, which is reviewing whether the novel radiation treatment proposed by Danbury Proton is warranted in Connecticut, will conduct the April 1 hearing online over the videoconferencing platform, Zoom.
The Danbury proposal is one of two “proton therapy” cancer centers under review in Connecticut. The second - a $72 million proposed center in Wallingford under a partnership between Hartford HealthCare and the Yale New Haven Health System, has already had an OHS public hearing.
Yale New Haven Health Deploys Virtual Clinic for Pediatric Patients with Diabetes
What You Should Know:
– After taking part in proving the clinical benefit of using AI-based decision support tools, as was recently published in Nature Medicine, Yale New Haven Health System and DreaMed Diabetes announced a collaboration that will explore what it would take to adopt such a solution into a real-world health system.
– As part of the collaboration, Yale New Haven will utilize DreaMed’s Advisor Pro platform to create a virtual clinic, this real-world evaluation will assess the onboarding of 100 pediatric patients with diabetes. Participants of the program will receive the benefits of optimization of their treatment regimen either in a fully remote treatment environment or with virtual visits supplementing the standard of care quarterly in-person visits they would have for the duration of six months. Continuous glucose monitor, or blood glucose monitor, data will be integrated with